Siriprogen Life Sciences Private Limited
About Siriprogen Life Sciences Private Limited
Data last updated:
Siriprogen Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 21 February 2023.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U21001TS2023PTC170757. Its GSTIN is 36ABKCS2658E1Z5 (Telangana).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Moram Sreenivasula Reddy and Thirunavukkarasu Shenbagavalli.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.27 Lakh, a decline of 19% compared to the previous year. For the same year it recorded a net profit of ₹68,207 (net margin 6.1%) and EBITDA of ₹2.73 Lakh (EBITDA margin 24.3%).
Company details
Contact details
Siriprogen Life Sciences Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressPlot No. #8 – 148/174/11, Nri Colony Pragathi Nagar, Hyderabad, Telangana, India – 500090
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Siriprogen Life Sciences is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Siriprogen Life Sciences Private Limited, buy the company report.
Financials of Siriprogen Life Sciences Private Limited
FY 2025 filings availableSiriprogen Life Sciences Private Limited reported revenue of ₹11.27 Lakh (down 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 19% in the latest year. EBITDA fell 15% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹2.73 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹68,207 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 24.3% | ||
| Net Profit Margin | 6.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Siriprogen Life Sciences Private Limited, buy the company report.
Board of directors of Siriprogen Life Sciences Private Limited
Siriprogen Life Sciences has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Moram Sreenivasula Reddy | Director | 21 Feb 2023 | 3 Years 8 Months | Current |
| Thirunavukkarasu Shenbagavalli | Director | 21 Feb 2023 | 3 Years 8 Months | Current |
| Venkata Ramana Ragoori | Director | 25 Sep 2025 | 1 Years 1 Months | Current |
| Rajeev Soni | Director | 25 Sep 2025 | 1 Years 1 Months | Current |
Peer comparison
Siriprogen Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of chemicals and chemical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Narbriton Health Care Pharmaceuticals Private Limited | ₹11.72 Lakh (FY 2024) | 90.0% | Delhi, India | |||
| Draven Life Sciences Private Limited | ₹11.71 Lakh (FY 2025) | 69.0% | Hyderabad, Telangana, India | |||
| Bhanuja Chemicals Private Limited | ₹11.64 Lakh (FY 2025) | Umargam, Gujarat, India | ||||
| Amit Cellulose Private Limited | ₹11.58 Lakh (FY 2025) | Mumbai, Maharashtra, India | ||||
| Nokha Guar Gum Industries Private Limited | ₹11.51 Lakh (FY 2024) | Nokha, Rajasthan, India | ||||
| Siriprogen Life Sciences Private Limitedthis company | ₹11.27 Lakh (FY 2025) | ₹68,207 | 6.1% | -19.0% | Hyderabad, Telangana, India | |
| Avm Shri Shyam Balaji Venture Private Limited | ₹11.19 Lakh (FY 2025) | -69.0% | Delhi, India | |||
| Sumiom Innovations Private Limited | ₹11.12 Lakh (FY 2025) | 30.0% | Delhi, India | |||
| Utshil Healthcare Private Limited | ₹10.97 Lakh (FY 2025) | 217.0% | Pune, Maharashtra, India | |||
| Aaj Life Science Chemicals Private Limited | ₹10.74 Lakh (FY 2025) | 100.0% | Ratnagiri, Maharashtra, India | |||
| Krisray Biotech Private Limited | ₹10.7 Lakh (FY 2025) | 13.0% | Faridabad, Haryana, India |
To see the full peer comparison of Siriprogen Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Siriprogen Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Siriprogen Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Siriprogen Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36ABKCS2658E1Z5 | Telangana | Active | 13 Mar 2023 |
To see the full GST registrations and return filing status of Siriprogen Life Sciences Private Limited, buy the company report.
Recent activity
Siriprogen Life Sciences Private Limited has 4 board changes on record since 2023: 4 appointments. The latest: Rajeev Soni was appointed as Director on 25 Sep 2025.
Frequently asked questions
Siriprogen Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in paper and paper products, within the paper industry. It was incorporated on 21 February 2023 (3+ years old) and is registered under CIN U21001TS2023PTC170757.
Siriprogen Life Sciences has 4 current directors:
- Moram Sreenivasula Reddy - Director
- Thirunavukkarasu Shenbagavalli - Director
- Venkata Ramana Ragoori - Director
- Rajeev Soni - Director
The latest financial statements of Siriprogen Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Siriprogen Life Sciences is 36ABKCS2658E1Z5, registered in Telangana.
The CIN (Corporate Identification Number) of Siriprogen Life Sciences is U21001TS2023PTC170757. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Siriprogen Life Sciences was incorporated on 21 February 2023, making it 3+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Siriprogen Life Sciences by revenue are Narbriton Health Care Pharmaceuticals Private Limited, Draven Life Sciences Private Limited, Bhanuja Chemicals Private Limited, Amit Cellulose Private Limited, Nokha Guar Gum Industries Private Limited and 5 more, all in the same principal business activity (manufacture of chemicals and chemical products).
Rajeev Soni was appointed as Director on 25 Sep 2025. Venkata Ramana Ragoori was appointed as Director on 25 Sep 2025. Moram Sreenivasula Reddy was appointed as Director on 21 Feb 2023. Siriprogen Life Sciences has 4 board changes on record in total.
The registered office of Siriprogen Life Sciences is at Plot No. #8 – 14817411, Nri Colony Pragathi Nagar, Hyderabad, Telangana, India – 500090.
Siriprogen Life Sciences operates in the paper industry, in the paper and paper products segment.
Siriprogen Life Sciences can be reached at its registered office: Plot No. #8 – 14817411, Nri Colony Pragathi Nagar, Hyderabad, Telangana, India – 500090.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
